SEC Orders Formal Inquiry into Frist Stock
Sale
Bloomberg
September 28,2005
Sept. 28 (Bloomberg) -- U.S. Senate Majority Leader Bill Frist faces a
near-term ordeal unwelcome to anyone, particularly an ambitious politician: an
official probe into his personal financial dealings by the U.S. Securities and
Exchange Commission.
The SEC authorized a formal order of investigation of Frist's sale in June
of HCA Inc. shares, people with direct knowledge of the inquiry said yesterday.
The order allows the agency's enforcement unit to subpoena documents and compel
witnesses to testify, said the people, who asked not to be identified because
the order hasn't been made public.
``This turns the flame up under the kettle and keeps the water boiling,''
said Stuart Rothenberg, editor of the independent Rothenberg Poltical Report in
Washington. ``It means he's going to continue to be peppered with questions
about this stock sale, and no politician wants to be questioned about things
like that.''
A formal order requires the approval of at least one of the SEC's five
commissioners. While it raises the legal stakes for Frist, a Tennessee
Republican, it doesn't indicate that the SEC's investigators have uncovered
evidence of illegal insider trading, said Michael Missal, a former enforcement
lawyer at the agency.
``Given the notoriety of this matter, presumably the SEC staff wants to make
absolutely sure it can get information quickly from sources other than Senator
Frist, who has already said he's cooperating,'' said Missal, now a partner at
Kirkpatrick & Lockhart Nicholson Graham in Washington.
Amy Call, a spokeswoman for Frist, didn't reply to a request for comment
after business hours yesterday. John Nester, an SEC spokesman, declined to
comment.
SEC Chairman
Christopher Cox, the agency's chairman and a former Republican lawmaker,
said Sept. 26 he would recuse himself from the case to avoid the ``appearance
of impropriety.''
Frist, the No. 1 Senate Republican and a possible presidential candidate in
2008, said Sept. 26 that he acted properly in selling the HCA shares, which
were held in a blind trust.
Frist's high profile may raise the stakes of any investigation, according to
Donald Langevoort, a former SEC lawyer and now a law professor at Georgetown
University in Washington. The SEC risked being second-guessed for political
reasons if it failed to conduct an exhaustive investigation, he said last
week.
Langevoort said a formal inquiry could mean demands from the SEC staff for
phone records, e-mails, witness testimony, and bank records.
The SEC's decision to step up its investigation means it will likely stretch
on for at least several weeks, and perhaps months, according to Missal, the
Kirkpatrick & Lockhart lawyer.
Earnings Notice
Frist, 53, directed the trustees of his blind trust to sell his shares on
June 13, one month before the company said its second-quarter earnings would
fail to meet analysts' estimates. The trustees notified Frist on July 1 that
the shares had been sold. When HCA issued its earnings notice on July 13, the
stock fell $4.86 to $50.05, the biggest decline in more than two years. During
the two-week period when Frist's sale occurred, the shares averaged $57.21,
reaching a 52-week high of $58.60 on June 22.
Nashville, Tennessee-based HCA, the biggest U.S. hospital chain, was founded
by Frist's father and brother, who serves as a director on the company's
board.
Justice Department
The Department of Justice is also investigating the matter. HCA said Sept.
23 that it received a subpoena from the U.S. attorney in Manhattan, and Frist
said he will cooperate with the prosecutor's office. HCA also said it ``intends
to cooperate fully.''
In his first public comments Sept. 26, Frist insisted he didn't have
non-public information before making the decision to sell. He also alluded to a
possible presidential bid, saying he wanted to put an end to persistent
questions about his HCA holdings as he prepared for his ``final years in the
Senate and what might come next.''
``An examination of the facts will demonstrate I acted properly,'' Frist
told reporters in Washington. ``I had no information about HCA or its
performance that was not publicly available when I directed the trustees to
sell the stock.''
Frist said he wanted to divest his shares to remove any possibility of a
conflict of interest on health-care policy, and in April asked his staff to
consult with outside counsel and Senate ethics committee staff to ensure the
rules permitted him to direct the sale. He said they found the sale was
allowed.
Two outside ethics groups -- Citizens for Responsibility and Ethics in
Washington and Common Cause -- have called on the Senate ethics committee to
look into the sales and Frist's communications with the trustee managing his
Senate-approved blind trust, which held the shares.
To contact the reporter on this story:
Otis Bilodeau in Washington at obilodeau@bloomberg.net.
Last Updated: September 28, 2005 00:07 EDT
|